Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Surveys and Questionnaires × Clear all

Sponsor

Conditions

Breast Neoplasms 10 cyclopia sequence 7 Neoplasms 6 Multiple Myeloma 5 Fatigue 5 Neoplasms, Plasma Cell 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Anxiety Disorders 4 Uterine Cervical Neoplasms 3 Tobacco Use Cessation 3 Primary Myelofibrosis 3 Leukemia 3 Dyspnea 3 Depression 3 Carcinoma, Non-Small-Cell Lung 3 Vomiting 2 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Parasomnias 2 Pancreatic Neoplasms 2 Pain 2 Osteosarcoma 2 Kidney Neoplasms 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Agnosia 2

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡